DRUG

Trailing Twelve Months (TTM) Metrics

Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-2.87
Operating CF/Share$-2.09
Free CF/Share$-2.09
Cash/Share$32.19
Book Value/Share$32.07
Tangible Book/Share$32.07
Equity/Share$32.07
Interest Debt/Share$0.01
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$1.10B
Enterprise Value$787.05M
P/E Ratio-33.02P/S Ratio0.00
P/OCF Ratio-53.51
P/FCF Ratio-54.61
P/B Ratio3.49
P/TB Ratio3.49
EV/Sales0.00
EV/EBITDA-25.13
Graham Valuation
Graham Number--
Graham Net-Net$31.88
Profitability
Earnings Yield-2.56%FCF Yield-1.83%ROE-20.73%ROIC-10.20%Return on Tangible Assets-8.83%
Dividend
Dividend Yield0.00%Payout Ratio0.00%
Capital Allocation
CapEx/OCF-0.00%
CapEx/Revenue0.00%
CapEx/Depreciation0.00
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00
Debt/Market Cap0.00
Net Debt/EBITDA9.85
Current Ratio81.48Interest Coverage-2438.56xIncome Quality0.73
Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding25030 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.01x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$307.52M
Working Capital$307.45M
Invested Capital$307.52M
Intangibles/Assets0.00%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.